Payers remain bullish on the managed Medicare segment as Medicare Advantage pushes toward 40 percent of the market. New models continue to be tested and new pharmacy initiatives could grow more widespread if initial efforts with insulin are successful. The pandemic has influenced the market, as seniors are more likely to suffer severe and potentially fatal complications from the virus.


Related Reports

Health Care Service Corp. | National MCO Analyzer | 2020

The proposed national settlement of a long-running Antitrust suit against the Blue Cross Blue Shield Association and the nationÕs Blue plans will force significant strategic changes for the...

View Details

Vermont | Medicaid Profile | National MCO Analyzer | 2020 (Event Driven)

State Medicaid Profiles offer a dashboard of key MCO players and enrollment, recent policy actions, and pharmacy trends for all 50 states, the District of Columbia, and Puerto Rico. Sections most...

View Details

Commercial Landscape | National MCO Analyzer | 2020

Between 10 million and 20 million Americans may lose their employer-sponsored health coverage because of the COVID-19 economic downturn during 2020. While some portion of these people will qualify...

View Details

Centene | National MCO Analyzer | 2020

With nearly a quarter of all MCO-managed Medicaid members enrolled in its plans, Centene dominates the Medicaid segment at a time when the COVID-19 economic downturn is expected to drive as many as...

View Details